相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Zinc-finger-based artificial transcription factors and their applications
Takashi Sera
ADVANCED DRUG DELIVERY REVIEWS (2009)
Novel activation domain derived from Che-1 cofactor coupled with the artificial protein Jazz drives utrophin upregulation
Agata Desantis et al.
NEUROMUSCULAR DISORDERS (2009)
Functional Substitution by TAT-Utrophin in Dystrophin-Deficient Mice
Kevin J. Sonnemann et al.
PLOS MEDICINE (2009)
Targeting Artificial Transcription Factors to the Utrophin A Promoter EFFECTS ON DYSTROPHIC PATHOLOGY AND MUSCLE FUNCTION
Yifan Lu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Microarray analysis of mdx mice expressing high levels of utrophin:: Therapeutic implications for dystrophin deficiency
Dilair Baban et al.
NEUROMUSCULAR DISORDERS (2008)
New therapies for Duchenne muscular dystrophy: challenges, prospects and clinical trials
Giulio Cossu et al.
TRENDS IN MOLECULAR MEDICINE (2007)
Utrophin Up-Regulation by an Artificial Transcription Factor in Transgenic Mice
Elisabetta Mattei et al.
PLOS ONE (2007)
The artificial 4-zinc-finger protein Bagly binds human utrophin promoter A at the endogenous chromosomal site and activates transcription
Annalisa Onori et al.
BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE (2007)
Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors
G. C. Minetti et al.
NATURE MEDICINE (2006)
Utrophin upregulation for treating Duchenne or Becker muscular dystrophy: how close are we?
P Miura et al.
TRENDS IN MOLECULAR MEDICINE (2006)
Engineering zinc finger protein transcription factors: The therapeutic relevance of switching endogenous gene expression on or off at command
WM Gommans et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
L-arginine improves dystrophic phenotype in mdx mice
V Voisin et al.
NEUROBIOLOGY OF DISEASE (2005)
The effect of peripheral nerve injury on disease progression in the SOD1 ((G93A)) mouse model of amyotrophic lateral sclerosis
PS Sharp et al.
NEUROSCIENCE (2005)
Heregulin ameliorates the dystrophic phenotype in mdx mice
TOB Krag et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatment - Third in Molecular Medicine Review Series
KJ Nowak et al.
EMBO REPORTS (2004)
Systemic delivery of genes to striated muscles using adeno-associated viral vectors
P Gregorevic et al.
NATURE MEDICINE (2004)
Designing transcription factor architectures for drug discovery
P Blancafort et al.
MOLECULAR PHARMACOLOGY (2004)
Pharmacological strategies for muscular dystrophy
TS Khurana et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Prevention of pathology in mdx mice by expression of utrophin:: analysis using an inducible transgenic expression system
S Squire et al.
HUMAN MOLECULAR GENETICS (2002)
Genetic variability in forced and voluntary endurance exercise performance in seven inbred mouse strains
I Lerman et al.
JOURNAL OF APPLIED PHYSIOLOGY (2002)
Function and genetics of dystrophin and dystrophin-related proteins in muscle
DJ Blake et al.
PHYSIOLOGICAL REVIEWS (2002)
Non-toxic ubiquitous over-expression of utrophin in the mdx mouse
R Fisher et al.
NEUROMUSCULAR DISORDERS (2001)
The artificial zinc finger coding gene 'Jazz' binds the utrophin promoter and activates transcription
N Corbi et al.
GENE THERAPY (2000)
分享论文
